Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 502 entries
Sorted by: Best Match Show Resources per page
[Choice of medicines].

Kangogaku zasshi

Sakuma A.
PMID: 4977882
Kangogaku Zasshi. 1969 Mar;33(3):66-7.

No abstract available.

Cite
Sakuma A. [Choice of medicines]. Kangogaku Zasshi. 1969;33(3):66-7
Sakuma, A. (1969). [Choice of medicines]. Kangogaku zasshi, 33(3), 66-7.
Sakuma, A. "[Choice of medicines]." Kangogaku zasshi vol. 33,3 (1969): 66-7.
Sakuma A. [Choice of medicines]. Kangogaku Zasshi. 1969 Mar;33(3):66-7. Japanese. PMID: 4977882.
Copy Download .nbib Format: NLM
[Clinical pharmacology].

Kangogaku zasshi

Sakuma A.
PMID: 4970845
Kangogaku Zasshi. 1968 Aug;32(8):66-7.

No abstract available.

Cite
Sakuma A. [Clinical pharmacology]. Kangogaku Zasshi. 1968;32(8):66-7
Sakuma, A. (1968). [Clinical pharmacology]. Kangogaku zasshi, 32(8), 66-7.
Sakuma, A. "[Clinical pharmacology]." Kangogaku zasshi vol. 32,8 (1968): 66-7.
Sakuma A. [Clinical pharmacology]. Kangogaku Zasshi. 1968 Aug;32(8):66-7. Japanese. PMID: 4970845.
Copy Download .nbib Format: NLM
[Theories of magnifying radiography].

Rinsho hoshasen. Clinical radiography

Takahashi S, Sasaki T, Takuma S, Koga S.
PMID: 5204656
Rinsho Hoshasen. 1971 Jan;16(1):1-6.

No abstract available.

Cite
Takahashi S, Sasaki T, Takuma S, et al. [Theories of magnifying radiography]. Rinsho Hoshasen. 1971;16(1):1-6
Takahashi, S., Sasaki, T., Takuma, S., & Koga, S. (1971). [Theories of magnifying radiography]. Rinsho hoshasen. Clinical radiography, 16(1), 1-6.
Takahashi, S, et al. "[Theories of magnifying radiography]." Rinsho hoshasen. Clinical radiography vol. 16,1 (1971): 1-6.
Takahashi S, Sasaki T, Takuma S, Koga S. [Theories of magnifying radiography]. Rinsho Hoshasen. 1971 Jan;16(1):1-6. Japanese. PMID: 5204656.
Copy Download .nbib Format: NLM
[Expectation on clinical application of nuclear magnetic resonance (NMR)].

Rinsho hoshasen. Clinical radiography

Nobechi T, Arimizu N, Iinuma T, Iio M, Sakuma S, Makino S.
PMID: 6842886
Rinsho Hoshasen. 1983 Jan;28(1):51-64.

No abstract available.

Cite
Nobechi T, Arimizu N, Iinuma T, et al. [Expectation on clinical application of nuclear magnetic resonance (NMR)]. Rinsho Hoshasen. 1983;28(1):51-64
Nobechi, T., Arimizu, N., Iinuma, T., Iio, M., Sakuma, S., & Makino, S. (1983). [Expectation on clinical application of nuclear magnetic resonance (NMR)]. Rinsho hoshasen. Clinical radiography, 28(1), 51-64.
Nobechi, T, et al. "[Expectation on clinical application of nuclear magnetic resonance (NMR)]." Rinsho hoshasen. Clinical radiography vol. 28,1 (1983): 51-64.
Nobechi T, Arimizu N, Iinuma T, Iio M, Sakuma S, Makino S. [Expectation on clinical application of nuclear magnetic resonance (NMR)]. Rinsho Hoshasen. 1983 Jan;28(1):51-64. Japanese. PMID: 6842886.
Copy Download .nbib Format: NLM
Pilot study of the short-term effects of range-of-motion exercise for the temporomandibular joint in patients with temporomandibular joint disc displacement without reduction.

Journal of physical therapy science

Sakuma S, Yamaguchi Y, Taguchi N, Ogi N, Kurita K, Ito Y.
PMID: 28265156
J Phys Ther Sci. 2017 Feb;29(2):274-277. doi: 10.1589/jpts.29.274. Epub 2017 Feb 24.

[Purpose] This study investigated the effectiveness of a short-term exercise program combining range-of-motion exercise for the temporomandibular joint and self-traction therapy in patients with temporomandibular joint disc displacement without reduction. [Subjects and Methods] The study participants comprised 36 females...

Cite
Sakuma S, Yamaguchi Y, Taguchi N, et al. Pilot study of the short-term effects of range-of-motion exercise for the temporomandibular joint in patients with temporomandibular joint disc displacement without reduction. J Phys Ther Sci. 2017;29(2):274-277doi: 10.1589/jpts.29.274.
Sakuma, S., Yamaguchi, Y., Taguchi, N., Ogi, N., Kurita, K., & Ito, Y. (2017). Pilot study of the short-term effects of range-of-motion exercise for the temporomandibular joint in patients with temporomandibular joint disc displacement without reduction. Journal of physical therapy science, 29(2), 274-277. https://doi.org/10.1589/jpts.29.274
Sakuma, Shigemitsu, et al. "Pilot study of the short-term effects of range-of-motion exercise for the temporomandibular joint in patients with temporomandibular joint disc displacement without reduction." Journal of physical therapy science vol. 29,2 (2017): 274-277. doi: https://doi.org/10.1589/jpts.29.274
Sakuma S, Yamaguchi Y, Taguchi N, Ogi N, Kurita K, Ito Y. Pilot study of the short-term effects of range-of-motion exercise for the temporomandibular joint in patients with temporomandibular joint disc displacement without reduction. J Phys Ther Sci. 2017 Feb;29(2):274-277. doi: 10.1589/jpts.29.274. Epub 2017 Feb 24. PMID: 28265156; PMCID: PMC5332987.
Copy Download .nbib Format: NLM
Autistic Traits Affect P300 Response to Unexpected Events, regardless of Mental State Inferences.

Autism research and treatment

Ishikawa M, Itakura S, Tanabe HC.
PMID: 28660082
Autism Res Treat. 2017;2017:8195129. doi: 10.1155/2017/8195129. Epub 2017 Jun 04.

Limited use of contextual information has been suggested as a way of understanding cognition in people with autism spectrum disorder (ASD). However, it has also been argued that individuals with ASD may have difficulties inferring others' mental states. Here,...

Cite
Ishikawa M, Itakura S, Tanabe HC. Autistic Traits Affect P300 Response to Unexpected Events, regardless of Mental State Inferences. Autism Res Treat. 2017;2017:8195129doi: 10.1155/2017/8195129.
Ishikawa, M., Itakura, S., & Tanabe, H. C. (2017). Autistic Traits Affect P300 Response to Unexpected Events, regardless of Mental State Inferences. Autism research and treatment, 20178195129. https://doi.org/10.1155/2017/8195129
Ishikawa, Mitsuhiko, et al. "Autistic Traits Affect P300 Response to Unexpected Events, regardless of Mental State Inferences." Autism research and treatment vol. 2017 (2017): 8195129. doi: https://doi.org/10.1155/2017/8195129
Ishikawa M, Itakura S, Tanabe HC. Autistic Traits Affect P300 Response to Unexpected Events, regardless of Mental State Inferences. Autism Res Treat. 2017;2017:8195129. doi: 10.1155/2017/8195129. Epub 2017 Jun 04. PMID: 28660082; PMCID: PMC5474239.
Copy Download .nbib Format: NLM
Virtual substrate method for nanomaterials characterization.

Nature communications

Da B, Liu J, Yamamoto M, Ueda Y, Watanabe K, Cuong NT, Li S, Tsukagoshi K, Yoshikawa H, Iwai H, Tanuma S, Guo H, Gao Z, Sun X, Ding Z.
PMID: 28548114
Nat Commun. 2017 May 26;8:15629. doi: 10.1038/ncomms15629.

Characterization techniques available for bulk or thin-film solid-state materials have been extended to substrate-supported nanomaterials, but generally non-quantitatively. This is because the nanomaterial signals are inevitably buried in the signals from the underlying substrate in common reflection-configuration techniques. Here,...

Cite
Da B, Liu J, Yamamoto M, et al. Virtual substrate method for nanomaterials characterization. Nat Commun. 2017;8:15629doi: 10.1038/ncomms15629.
Da, B., Liu, J., Yamamoto, M., Ueda, Y., Watanabe, K., Cuong, N. T., Li, S., Tsukagoshi, K., Yoshikawa, H., Iwai, H., Tanuma, S., Guo, H., Gao, Z., Sun, X., & Ding, Z. (2017). Virtual substrate method for nanomaterials characterization. Nature communications, 815629. https://doi.org/10.1038/ncomms15629
Da, Bo, et al. "Virtual substrate method for nanomaterials characterization." Nature communications vol. 8 (2017): 15629. doi: https://doi.org/10.1038/ncomms15629
Da B, Liu J, Yamamoto M, Ueda Y, Watanabe K, Cuong NT, Li S, Tsukagoshi K, Yoshikawa H, Iwai H, Tanuma S, Guo H, Gao Z, Sun X, Ding Z. Virtual substrate method for nanomaterials characterization. Nat Commun. 2017 May 26;8:15629. doi: 10.1038/ncomms15629. PMID: 28548114; PMCID: PMC5458549.
Copy Download .nbib Format: NLM
Heterozygosity for leptin receptor (fa) accelerates hepatic triglyceride accumulation without hyperphagia in Zucker rats.

Obesity research & clinical practice

Himeno K, Seike M, Fukuchi S, Masaki T, Kakuma T, Sakata T, Yoshimatsu H.
PMID: 24345539
Obes Res Clin Pract. 2009 Mar;3(1):1-52. doi: 10.1016/j.orcp.2008.10.003.

SUMMARY: Leptin, ob gene product, and its receptors are involved in the regulation of peripheral lipid and glucose metabolism. The present study sought to clarify the functional role of peripheral leptin receptors in hepatic lipid metabolism through analysis of...

Cite
Himeno K, Seike M, Fukuchi S, et al. Heterozygosity for leptin receptor (fa) accelerates hepatic triglyceride accumulation without hyperphagia in Zucker rats. Obes Res Clin Pract. 2009;3(1):1-52doi: 10.1016/j.orcp.2008.10.003.
Himeno, K., Seike, M., Fukuchi, S., Masaki, T., Kakuma, T., Sakata, T., & Yoshimatsu, H. (2009). Heterozygosity for leptin receptor (fa) accelerates hepatic triglyceride accumulation without hyperphagia in Zucker rats. Obesity research & clinical practice, 3(1), 1-52. https://doi.org/10.1016/j.orcp.2008.10.003
Himeno, Katsuro, et al. "Heterozygosity for leptin receptor (fa) accelerates hepatic triglyceride accumulation without hyperphagia in Zucker rats." Obesity research & clinical practice vol. 3,1 (2009): 1-52. doi: https://doi.org/10.1016/j.orcp.2008.10.003
Himeno K, Seike M, Fukuchi S, Masaki T, Kakuma T, Sakata T, Yoshimatsu H. Heterozygosity for leptin receptor (fa) accelerates hepatic triglyceride accumulation without hyperphagia in Zucker rats. Obes Res Clin Pract. 2009 Mar;3(1):1-52. doi: 10.1016/j.orcp.2008.10.003. PMID: 24345539.
Copy Download .nbib Format: NLM
Telmisartan reduced abdominal circumference and body weight with decreasing triglyceride level in patients with type 2 diabetes and metabolic syndrome.

Obesity research & clinical practice

Kakuma T, Gotoh K, Masaki T, Itateyama E, Abe N, Yoshimatsu H.
PMID: 24345653
Obes Res Clin Pract. 2010 Apr-Jun;4(2):e83-e162. doi: 10.1016/j.orcp.2009.12.003.

SUMMARY: Telmisartan has the dual ability to inhibit angiotensin II type 1 receptors and activate peroxisome proliferator-activated receptor gamma (PPAR), especially as a selective PPAR modulator that does not strongly promote adipogenesis for weight gain. Accordingly, Telmisartan is expected...

Cite
Kakuma T, Gotoh K, Masaki T, et al. Telmisartan reduced abdominal circumference and body weight with decreasing triglyceride level in patients with type 2 diabetes and metabolic syndrome. Obes Res Clin Pract. 2010;4(2):e83-e162doi: 10.1016/j.orcp.2009.12.003.
Kakuma, T., Gotoh, K., Masaki, T., Itateyama, E., Abe, N., & Yoshimatsu, H. (2010). Telmisartan reduced abdominal circumference and body weight with decreasing triglyceride level in patients with type 2 diabetes and metabolic syndrome. Obesity research & clinical practice, 4(2), e83-e162. https://doi.org/10.1016/j.orcp.2009.12.003
Kakuma, Tetsuya, et al. "Telmisartan reduced abdominal circumference and body weight with decreasing triglyceride level in patients with type 2 diabetes and metabolic syndrome." Obesity research & clinical practice vol. 4,2 (2010): e83-e162. doi: https://doi.org/10.1016/j.orcp.2009.12.003
Kakuma T, Gotoh K, Masaki T, Itateyama E, Abe N, Yoshimatsu H. Telmisartan reduced abdominal circumference and body weight with decreasing triglyceride level in patients with type 2 diabetes and metabolic syndrome. Obes Res Clin Pract. 2010 Apr-Jun;4(2):e83-e162. doi: 10.1016/j.orcp.2009.12.003. PMID: 24345653.
Copy Download .nbib Format: NLM
Semaphorin 3A promotes activation of Pax7, Myf5, and MyoD through inhibition of emerin expression in activated satellite cells.

FEBS open bio

Qahar M, Takuma Y, Mizunoya W, Tatsumi R, Ikeuchi Y, Nakamura M.
PMID: 27239431
FEBS Open Bio. 2016 Apr 27;6(6):529-39. doi: 10.1002/2211-5463.12050. eCollection 2016 Jun.

We previously showed that Semaphorin 3A (Sema3A) expression was induced when quiescent muscle satellite cells were stimulated by hepatocyte growth factor and became activated satellite cells (ASCs). However, how Sema3A regulates genes in the early phase of ASCs remains...

Cite
Qahar M, Takuma Y, Mizunoya W, et al. Semaphorin 3A promotes activation of Pax7, Myf5, and MyoD through inhibition of emerin expression in activated satellite cells. FEBS Open Bio. 2016;6(6):529-39doi: 10.1002/2211-5463.12050.
Qahar, M., Takuma, Y., Mizunoya, W., Tatsumi, R., Ikeuchi, Y., & Nakamura, M. (2016). Semaphorin 3A promotes activation of Pax7, Myf5, and MyoD through inhibition of emerin expression in activated satellite cells. FEBS open bio, 6(6), 529-39. https://doi.org/10.1002/2211-5463.12050
Qahar, Mulan, et al. "Semaphorin 3A promotes activation of Pax7, Myf5, and MyoD through inhibition of emerin expression in activated satellite cells." FEBS open bio vol. 6,6 (2016): 529-39. doi: https://doi.org/10.1002/2211-5463.12050
Qahar M, Takuma Y, Mizunoya W, Tatsumi R, Ikeuchi Y, Nakamura M. Semaphorin 3A promotes activation of Pax7, Myf5, and MyoD through inhibition of emerin expression in activated satellite cells. FEBS Open Bio. 2016 Apr 27;6(6):529-39. doi: 10.1002/2211-5463.12050. eCollection 2016 Jun. PMID: 27239431; PMCID: PMC4880721.
Copy Download .nbib Format: NLM
Anxiety and Depression as Predictors of Recurrence in Geriatric Depression: A Preliminary Report.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

Meyers BS, Gabriele M, Kakuma T, Ippolito L, Alexopoulos G.
PMID: 28531084
Am J Geriatr Psychiatry. 1996 Summer;4(3):252-257. doi: 10.1097/00019442-199622430-00009. Epub 2012 Aug 14.

The authors studied elderly patients with major depression (MDD) who recovered after nortriptyline treatment to determine the relationship of affective symptoms at completion of continuation treatment to eventual MDD recurrence. Independent objective measures of depressive and anxiety symptoms were...

Cite
Meyers BS, Gabriele M, Kakuma T, et al. Anxiety and Depression as Predictors of Recurrence in Geriatric Depression: A Preliminary Report. Am J Geriatr Psychiatry. 2012;4(3):252-257doi: 10.1097/00019442-199622430-00009.
Meyers, B. S., Gabriele, M., Kakuma, T., Ippolito, L., & Alexopoulos, G. (1996). Anxiety and Depression as Predictors of Recurrence in Geriatric Depression: A Preliminary Report. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 4(3), 252-257. https://doi.org/10.1097/00019442-199622430-00009
Meyers, Barnett S, et al. "Anxiety and Depression as Predictors of Recurrence in Geriatric Depression: A Preliminary Report." The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry vol. 4,3 (1996): 252-257. doi: https://doi.org/10.1097/00019442-199622430-00009
Meyers BS, Gabriele M, Kakuma T, Ippolito L, Alexopoulos G. Anxiety and Depression as Predictors of Recurrence in Geriatric Depression: A Preliminary Report. Am J Geriatr Psychiatry. 1996 Summer;4(3):252-257. doi: 10.1097/00019442-199622430-00009. Epub 2012 Aug 14. PMID: 28531084.
Copy Download .nbib Format: NLM
Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy.

International journal of endocrinology

Eguchi H, Tani J, Hirao S, Tsuruta M, Tokubuchi I, Yamada K, Kasaoka M, Teshima Y, Kakuma T, Hiromatsu Y.
PMID: 26221141
Int J Endocrinol. 2015;2015:835979. doi: 10.1155/2015/835979. Epub 2015 Jun 28.

Intravenous methylprednisolone (IVMP) pulse therapy is the first-line treatment for the active phase of moderate to severe Graves' orbitopathy (GO). However, acute and severe liver damage has been reported during and after IVMP therapy. In this retrospective study, we...

Cite
Eguchi H, Tani J, Hirao S, et al. Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy. Int J Endocrinol. 2015;2015:835979doi: 10.1155/2015/835979.
Eguchi, H., Tani, J., Hirao, S., Tsuruta, M., Tokubuchi, I., Yamada, K., Kasaoka, M., Teshima, Y., Kakuma, T., & Hiromatsu, Y. (2015). Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy. International journal of endocrinology, 2015835979. https://doi.org/10.1155/2015/835979
Eguchi, Hiroyuki, et al. "Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy." International journal of endocrinology vol. 2015 (2015): 835979. doi: https://doi.org/10.1155/2015/835979
Eguchi H, Tani J, Hirao S, Tsuruta M, Tokubuchi I, Yamada K, Kasaoka M, Teshima Y, Kakuma T, Hiromatsu Y. Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy. Int J Endocrinol. 2015;2015:835979. doi: 10.1155/2015/835979. Epub 2015 Jun 28. PMID: 26221141; PMCID: PMC4499413.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 502 entries